Przegląd Dermatologiczny

Full text

1/2026 vol. 113
Case report

Hallopeau-Type Pemphigus Vegetans Emerging Under Long-Term Oral Prednisone Therapy

Azzahra Wiana Kartika Siregar 1
,
Otto Ahvonen 2
,
Madina Shahmarova 3
,
Maja Kleniewska 4
,
Agnieszka Markiewicz 4
,
Agnieszka Owczarczyk-Saczonek 4

  1. Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia

  2. Faculty of Medicine, University of Eastern, Finland

  3. Faculty of Medicine, University of Tartu, Estonia

  4. Department of Dermatology, Sexually Transmitted Diseases and Clinical Immunology, The University of Warmia and Mazury, Olsztyn, Poland


Dermatol Rev/Przegl Dermatol 2026, 113, 54–59

DOI: https://doi.org/10.5114/dr.2026.161426
Data publikacji online: 2026/06/05
Article file
Hallopeau-Type Pemphigus.pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
  1. Amagai M.: Pemphigus. In: Dermatology. 4th ed. J. Bolognia, J.V. Schaffer, L. Cerroni, editors. Elsevier, Philadelphia 2018, 494-509.
  2. Payne A.S., Stanley J.R.: Pemphigus. In: Fitzpatrick’s Dermatology. 9th ed. S. Kang, M. Amagai, A.L. Bruckner, A.H. Enk, D.J. Margolis, A.J. McMichael, et al. editors. McGraw-Hill Education, New York 2019, 909-933.
  3. Langan S.M., Smeeth L., Hubbard R., Fleming K.M., Smith C.J.P., West J.: Bullous pemphigoid and pemphigus vulgaris: incidence and mortality in the UK: population-based cohort study. BMJ 2008, 337, a180.
  4. Min M.S., Damstetter E., Chen A.Y.Y.: Autoimmune blistering disorders in the setting of human immunodeficiency virus infection. Int J Womens Dermatol 2018, 4, 159-165.
  5. Ruocco V., Ruocco E., Caccavale S., Gambardella A., Lo Schiavo A.: Pemphigus vegetans of the folds (intertriginous areas). Clin Dermatol 2015, 33, 471-476.
  6. von Köckritz A., Ständer S., Zeidler C., Metze D., Luger T., Bonsmann G.: Successful monotherapy of pemphigus vegetans with minocycline and nicotinamide. J Eur Acad Dermatol Venereol 2017, 31, 85-88.
  7. Mergler R., Kerstan A., Schmidt E., Goebeler M., Benoit S. : Atypical clinical and serological manifestation of pemphigus vegetans: a case report and review of the literature. Case Rep Dermatol 2017, 9, 121-130.
  8. Zaraa I., Sellami A., Bouguerra C., Sellami M.K., Chelly I., Zitouna M., et al.: Pemphigus vegetans: a clinical, histological, immunopathological and prognostic study. J Eur Acad Dermatol Venereol 2011, 25, 1160-1167.
  9. Jain V., Jindal N., Imchen S.: Localized pemphigus vegetans without mucosal involvement. Indian J Dermatol 2014, 59, 210.
  10. Messersmith L., Krauland K.: Pemphigus vegetans. StatPearls [Internet]. 2024.
  11. Mendes-Bastos P., Amaro C., Fernandes C.: Cobblestone mouth: an exuberant oral presentation of pemphigus vegetans. Actas Dermosifiliogr 2015, 106, 72-73.
  12. Prachi B., Fernandes E., Thara G.S.N., Rakhi G.: Triggered pemphigus with Koebner phenomenon: a coincidence? Clin Dermatol Rev 2024, 8, 76-78.
  13. Jetter N., Cerci F.B., Pandher K., Krunic A.L.: Pemphigus vegetans developing after Mohs micrographic surgery and cryotherapy. An Bras Dermatol 2021, 96, 520-523.
  14. Cuellar I., Mejia M., Castellanos-Angarita A., Casas-Barrera M.A.: Hallopeau type of pemphigus vegetans, an unusual clinical presentation of an infrequent disease. Dermatol Online J 2020, 26, 13030/qt91q8q1f1.
  15. Hayashida K., Yamakawa S.: Topical odour management in burn patients. Burns Trauma 2021, 9, tkab025.
  16. Rhen T., Cidlowski J.A.: Anti-inflammatory action of glucocorticoids: new mechanisms for old drugs. N Engl J Med 2005, 353, 1711-1723.
  17. Kurien G., Jamil R.T., Preuss C.V.: Dapsone. StatPearls [Internet]. 2025.
  18. Son Y.M., Kang H.K., Yun J.H., Roh J.Y., Lee J.R.: The Neumann type of pemphigus vegetans treated with combination of dapsone and steroid. Ann Dermatol 2011, 23 (Suppl 3), S310.
  19. Ciarrocca K.N., Greenberg M.S.: A retrospective study of the management of oral mucous membrane pemphigoid with dapsone. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999, 88, 159-163.
  20. Quaresma M.V., Bernardes Filho F., Hezel J., Peretti M.C., Kac B.K., Azulay-Abulafia L.: Dapsone in the treatment of pemphigus vulgaris: adverse effects and its importance as a corticosteroid-sparing agent. An Bras Dermatol 2015, 90 (3 Suppl 1), 51-54.
  21. Ellebrecht C.T., Payne A.S.: Setting the target for pemphigus vulgaris therapy. JCI Insight 2017, 2, e92021.
  22. Kavala M., Topaloğlu Demir F., Zindanci I., Can B., Turkoğlu Z., Zemheri E., et al.: Genital involvement in pemphigus vulgaris: correlation with clinical and cervicovaginal Pap smear findings. J Am Acad Dermatol 2015, 73, 655-659.
Copyright: © 2026 Polish Dermatological Association. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Indeks osobowy
Share
without publication fees
without publication fees
Coverage in
Integrated with
plagiat pl
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications